Lozano Iñigo, Avanzas Pablo, Lee Dae-Hyun, Lasa Garikoitz, Rondán Juan, Moris César
Servicio de Cardiología, Hospital Universitario Central de Asturias, Oviedo, Spain.
J Invasive Cardiol. 2007 Jan;19(1):27-31.
Bifurcated lesions are associated with higher complexity and restenosis. Sometimes implantation of two stents is necessary, requiring larger guiding catheters. We describe the implantation of two drug-eluting stents (DES) utilizing the balloon-crushing technique and 6 Fr catheters.
This was a prospective and observational study of a cohort of 15 consecutive patients with 1 bifurcated lesion treated with 2 DES through a 6 Fr catheter and the balloon-crushing technique between April and November 2005. The baseline characteristics of the patients, lesions and procedures were registered. Clinical follow up was obtained by telephone contact.
Patient age ranged from 71.6+/- 9.4 years; 6 patients (40%) had diabetes; ejection fraction was 56 +/- 12%; radial access was used in 4 patients (26.6%). In 9 patients (60%) the target lesion was the left main artery; in 3 patients (20%) the target lesion was the LAD/diagonal and in the remaining 3 patients (20%), the target lesion was the circumflex/obtuse marginal. The median follow-up period was 316 days. There were 2 sudden deaths: 1 patient whose target lesion was the left main artery died 10 days following the procedure, and the other patient whose lesion was in the in LAD/diagonal died at day-187, 10 days following stent thrombosis. Both of them presented with severe ventricular dysfunction prior to the intervention. One patient required new percutaneous intervention due to in-segment restenosis in the left main artery. The composite major adverse cardiac events at follow up was 5 (33.3%, 2 deaths, 2 non-Q-wave myocardial infarctions and 1 revascularization).
This technique permits the treatment of bifurcated lesions with 2 stents using 6 Fr guiding catheters, which could be very useful in radial access procedures. However, though the angiographic results were very satisfactory, the events observed in the follow-up period require a word of caution about its mid-term safety.
分叉病变与更高的复杂性和再狭窄相关。有时需要植入两个支架,这就需要更大的引导导管。我们描述了使用球囊挤压技术和6F导管植入两个药物洗脱支架(DES)的方法。
这是一项前瞻性观察研究,对2005年4月至11月期间连续15例患有1个分叉病变的患者进行队列研究,通过6F导管和球囊挤压技术用2个DES进行治疗。记录患者、病变和手术的基线特征。通过电话联系进行临床随访。
患者年龄范围为71.6±9.4岁;6例患者(40%)患有糖尿病;射血分数为56±12%;4例患者(26.6%)采用桡动脉入路。9例患者(60%)的靶病变为左主干;3例患者(20%)的靶病变为前降支/对角支,其余3例患者(20%)的靶病变为回旋支/钝缘支。中位随访期为316天。有2例猝死:1例靶病变为左主干的患者在手术后10天死亡,另1例病变位于前降支/对角支的患者在第187天,即支架血栓形成后10天死亡。他们在干预前均表现为严重的心室功能障碍。1例患者因左主干节段内再狭窄需要再次进行经皮介入治疗。随访时的复合主要不良心脏事件为5例(33.3%,2例死亡,2例非Q波心肌梗死和1例血运重建)。
该技术允许使用6F引导导管用2个支架治疗分叉病变,这在桡动脉入路手术中可能非常有用。然而,尽管血管造影结果非常令人满意,但随访期间观察到的事件需要对其中期安全性予以谨慎对待。